tailieunhanh - 5-fluorouracil encapsulated CS-mPEG nanogels for controlling drug release

The purpose of this study is to synthesize and characterize poly (ethylene glycol) methyl ether (mPEG) conjugated chitosan (CS), mPEG-CS, at different ratios of 5-Fluorouracil (5-FU) delivery (5-FU-loaded mPEG-CS). The chemical cross-linking of these polymers were prepared by using 4-Nitrophenyl chloroformate reagent. The obtained mPEG-CS was characterized by Fourier transform infrared (FTIR) and proton nuclear magnetic resonance (1H NMR) spectroscopy. | Vietnam Journal of Chemistry, International Edition, 55(4): 446-449, 2017 DOI: 5-fluorouracil encapsulated CS-mPEG nanogels for controlling drug release Nguyen Dai Hai Institute of Applied Materials Science, Vietnam Academy of Science and Technology Received 29 December 2016; Accepted for publication 28 August 2017 Abstract The purpose of this study is to synthesize and characterize poly (ethylene glycol) methyl ether (mPEG) conjugated chitosan (CS), mPEG-CS, at different ratios of 5-Fluorouracil (5-FU) delivery (5-FU-loaded mPEG-CS). The chemical cross-linking of these polymers were prepared by using 4-Nitrophenyl chloroformate reagent. The obtained mPEG-CS was characterized by Fourier transform infrared (FTIR) and proton nuclear magnetic resonance ( 1H NMR) spectroscopy. The 5-FU-loaded mPEG-CS particles were nearly spherical in shape with a mean diameter of nm, determined by transmission electron microscopy (TEM). In addition, the entrapment efficiency of 5-FU was approximately 10 %. Whereas the encapsulation efficiency and loading capacity were independent of different molar ratios of mPEG, there was one factor that particularly stands out, which is 5-FU release behavior. These results indicated that mPEG-CS nanogels present the potential for controlled release of 5-FU working as a delivery system in cancer therapy. Keywords. Poly(ethylene glycol) methyl ether, chitosan, 5-fluorouracil, nanogels, drug delivery system. 1. INTRODUCTION Drug delivery system (DDS) has been an outstanding subject of studying and developing as an original method to control drug release in the blood stream for reducing toxic side-effects in patients. DDS tends to particularly localize and target the drug within desired therapeutic range to expected tissue and cells while maintaining the systemic level of drugs [1]. In order to reach these intentions, nanomaterials (NMs) possess enormous advantages: i) protecting sensitive drug molecules .

TỪ KHÓA LIÊN QUAN
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.